Inventor

OSTERROTH FRANK

DE14 patents

⚠️ This page may combine multiple inventors who share the name “OSTERROTH FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OSTERROTH FRANK

5 patents

US8956607B2Feb 17, 2015

Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE)

OSTERROTH FRANK7 citations81

US9289509B2Mar 22, 2016

Uses of immunoconjugates targeting CD138

OSTERROTH FRANK10 citations79

US9334325B2May 10, 2016

Method for treating psoriasis

OSTERROTH FRANK2 citations59

US8852871B2Oct 7, 2014

Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)

OSTERROTH FRANK3 citations58

US9995733B2Jun 12, 2018

Agents for treating disease

OSTERROTH FRANK1 citations47

BIOTEST AG

3 patents

US10117932B2Nov 6, 2018

Uses of immunoconjugates targeting CD138

BIOTEST AG7 citations80

US9540436B2Jan 10, 2017

Use of antibodies for detection of IL-10

BIOTEST AG0 citations49

US9605066B2Mar 28, 2017

Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)

BIOTEST AG0 citations48

KRAUS ELMAR

2 patents

US9221914B2Dec 29, 2015

Agents targeting CD138 and uses thereof

KRAUS ELMAR6 citations69

US9387261B2Jul 12, 2016

Immunoconjugates targeting CD138 and uses thereof

KRAUS ELMAR4 citations68

DAELKEN BENJAMIN

1 patent

US9446146B2Sep 20, 2016

Methods and agents for improving targeting of CD138 expressing tumor cells

DAELKEN BENJAMIN10 citations78

SCHULZ GREGOR

1 patent

US9011864B2Apr 21, 2015

Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates

SCHULZ GREGOR19 citations78

AIGNER SILKE

1 patent

US9550831B2Jan 24, 2017

Method for treating psoriasis

AIGNER SILKE1 citations43

GERMER MATTHIAS

1 patent

US9512226B2Dec 6, 2016

Agent for treating disease

GERMER MATTHIAS0 citations42